Jacques Mizrahi

Jacques Mizrahi Ph.D, has been a senior executive with 20 plus years of big pharma global leadership experience in Discovery and Development (GSK, E. Lilly, Roche). Jacques has led several successful drug development programs in vascular, cardiovascular and metabolic diseases. At Roche, as Global Therapy Area Head, he led the discovery and development of several new molecular entities for Acute Coronary Syndromes, Diabetes and Diabetes complications and has developed significant expertise in bridging the discovery of new target pathways and the clinics via translational medicine projects. Jacques obtained his Ph.D in Pharmacology from the University of Sherbrooke, Canada and then held postdoctoral fellowships at each of Sherbrooke Medical School and at INSERM Paris where he focused on protein biochemistry. Jacques has over 100 peer reviewed publications. Additionally, he contributes to peer journal Editorial Boards and sits on Advisory Boards of academic, biotech and venture capital organizations.